{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:24:29Z","timestamp":1787840669510,"version":"build-2784847793"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Although blood sugar abnormalities have been reported during the COVID-19 pandemic due to ongoing virus-related effects on insulin secretory effects on the pancreas and stress and steroids used during management, its long-term effects remain unknown. Real-world data on blood sugar abnormalities in follow-up with special emphasis on new-onset diabetes mellitus (DM) or unmasking ongoing DM is an issue of concern that remains underestimated and under-evaluated in clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Prospective, observational cohort study conducted between January 2021 and December 2022 included 800 COVID-19 patients above 18 years of age, irrespective of their disease severity and comorbidity, after a valid written consent. All the study cases were followed for 6 months after discharge from the hospital. Protocolled recording of covariates such as blood sugar (fasting, postprandial, and random), HbA1c, blood pressure, anthropometric indices, electrocardiogram, lipid profile, and uric acid was done at the entry point. Documentation of indoor records such as computed tomography (CT) Severity scores into mild (score &lt;8), moderate (score 9\u201315), and severe (score &gt;15); inflammatory markers such as interleukin-6, ferritin, C-reactive protein, lactate dehydrogenase and D-dimer, and interventions used during hospitalization such as oxygen supplementation and oxygen plus BIPAP\/NIV were done as a protocol. Statistical analysis was done using the Chi-square test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the present study, blood sugar abnormalities as preexisting DM with aggravation noted in 12.75% (102\/800), post-COVID-19 transient hyperglycemia in 43.75% (290\/800), post-COVID-19 new-onset DM in transient group in 17.14% (60\/350), post-COVID-19 new-onset DM in 8.59% (60\/698) and no DM or hyperglycemia in 43.5% (348\/800) cases [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001]. A significant association was observed between interventions used, such as oxygen and oxygen plus BIPAP\/NIV requirement, and cases without interventions with blood sugar profile such as new-onset DM, preexistent DM with aggravation, post-COVID-19 transient hyperglycemia and no DM or hyperglycemia (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). A significant association was observed in blood sugar level switch from normoglycemic to transient hyperglycemic to DM range during pre-COVID-19 to post-COVID-19 state in follow-up (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). Covariates analysis such as age, gender, body mass index observed a significant association with cases with new-onset DM, preexistent DM with aggravation, post-COVID-19 transient hyperglycemia and no DM (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). Comorbidities such as hypertension and IHD observed significant association with blood sugar profile in study cases in post-COVID-19 setting (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001). Inflammatory markers during hospitalization, high-resolution CT severity score, and uric acid analysis during follow-up documented significant association with new-onset DM, preexistent DM with aggravation, post-COVID-19 transient hyperglycemia and no DM or hyperglycemia during post-COVID-19 follow-up (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>COVID-19 has been associated with blood sugar abnormalities such as transient hyperglycemia, aggravation of underlying DM as a result of the ongoing disease process, and treatment options used during management in indoor settings. Inflammatory markers during hospitalization, interventions used during indoor period, and severity of COVID-19 illness in chest imaging have a positive association with blood sugar abnormalities. Proportionate number of transient hyperglycemia cases has evolved toward new-onset DM cases in 6-month post-COVID-19 follow-up. COVID-19 illness has played a role in unmasking new-onset DM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/aam.aam_20_25","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T03:00:07Z","timestamp":1749610807000},"page":"888-897","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Does Ongoing Inflammation in Recovered COVID-19 Disease Aggravates Preexistent Diabetes Mellitus or Unmasks New-onset Diabetes Mellitus? A Single-center Experience of 800 Cases at 6-month Follow-up"],"prefix":"10.4103","volume":"24","author":[{"given":"Shital","family":"Patil","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, Venkatesh Chest Hospital and Critical Care Center, Latur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devang","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, MIMSR Medical College, Latur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan","family":"Gondhali","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, MIMSR Medical College, Latur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"R1-20251015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1631\/jzus.B2000083","article-title":"An overview of COVID-19","volume":"21","author":"Shi","year":"2020","journal-title":"J Zhejiang Univ Sci B"},{"key":"R2-20251015","doi-asserted-by":"crossref","first-page":"102947","DOI":"10.1016\/j.autrev.2021.102947","article-title":"Post-COVID syndrome. A case series and comprehensive review","volume":"20","author":"Anaya","year":"2021","journal-title":"Autoimmun Rev"},{"key":"R3-20251015","doi-asserted-by":"crossref","first-page":"n693","DOI":"10.1136\/bmj.n693","article-title":"Post-COVID syndrome in individuals admitted to hospital with COVID-19: Retrospective cohort study","volume":"372","author":"Ayoubkhani","year":"2021","journal-title":"BMJ"},{"key":"R5-20251015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"R6-20251015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1463-1326.2006.00612.x","article-title":"A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians \u2013The Chennai Urban Rural Epidemiology Study (CURES-38)","volume":"9","author":"Mohan","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"R7-20251015","first-page":"217","article-title":"Epidemiology of type 2 diabetes: Indian scenario","volume":"125","author":"Mohan","year":"2007","journal-title":"Indian J Med Res"},{"key":"R8-20251015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"R9-20251015","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","author":"Gavin","year":"1997","journal-title":"Diabetes Care"},{"key":"R10-20251015","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/edrv.19.4.0338","article-title":"The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity","volume":"19","author":"Gerich","year":"1998","journal-title":"Endocr Rev"},{"issue":"Suppl 2","key":"R11-20251015","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1055\/s-2001-18576","article-title":"Insulin resistance: Definition and consequences","volume":"109","author":"Lebovitz","year":"2001","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"Suppl 1","key":"R12-20251015","first-page":"S5","article-title":"Perioperative management of adult diabetic patients. Review of hyperglycaemia: Definitions and pathophysiology","volume":"37","author":"Cheisson","year":"2018","journal-title":"Anaesth Crit Care Pain Med"},{"key":"R14-20251015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with COVID-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"R15-20251015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"R16-20251015","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/ijms18030563","article-title":"Characterization of ACE and ACE2 expression within different organs of the NOD mouse","volume":"18","author":"Roca-Ho","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R17-20251015","doi-asserted-by":"crossref","first-page":"1215879","DOI":"10.3389\/fendo.2023.1215879","article-title":"Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis","volume":"14","author":"Bellia","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"R18-20251015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/japt.japt_6_22","article-title":"Serial interleukin-6 titer monitoring in COVID-19 pneumonia: Valuable inflammatory marker in assessment of severity, predicting ventilatory support requirement, and final radiological outcome \u2013Prospective observational study in tertiary care setting in India","volume":"5","author":"Patil","year":"2022","journal-title":"J Assoc Pulmonologist"},{"key":"R19-20251015","doi-asserted-by":"crossref","first-page":"em390","DOI":"10.29333\/ejgm\/12191","article-title":"Role of initial and follow-up IL-6 (Interleukin-6) titre in COVID-19 pneumonia: A single center experience","volume":"19","author":"Patil","year":"2022","journal-title":"Electron J Gen Med"},{"key":"R20-20251015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/ecdt.ECDT_48_22","article-title":"Role of interleukin-6 in coronavirus disease 2019 pneumonia: Sensitive marker of inflammation, a predictor of ventilatory support and early marker of post-coronavirus disease lung fibrosis. A single center experience","volume":"72","author":"Patil","year":"2023","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"R21-20251015","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/amsr.amsr_3_23","article-title":"Role of interleukin-6 in COVID-19 pneumonia as marker of cytokine storm and predictor of course during hospitalization: Prospective, observational study in tertiary care setting in India","volume":"2","author":"Patil","year":"2023","journal-title":"Ann Med Sci Res"},{"key":"R22-20251015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.25259\/SRJHS_17_2022","article-title":"Role of IL-6 as 'core inflammatory marker'in assessment of severity, response to therapy and predicting outcome in COVID-19 pneumonia: A single center experience of 2400 cases in tertiary care setting in India","volume":"3","author":"Patil","year":"2023","journal-title":"Sri Ramachandra J Health Sci"},{"key":"R23-20251015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4103\/jalh.jalh_20_22","article-title":"The role of initial and follow-up C-reactive protein titer in COVID-19 pneumonia: A single-center study of 1000 cases in a tertiary care setting in India","volume":"3","author":"Patil","year":"2023","journal-title":"J Adv Lung Health"},{"key":"R24-20251015","first-page":"112","article-title":"Serial CRP (C-reactive protein) monitoring in COVID-19 pneumonia for the assessment of severity, ventilatory support requirement and predicting early lung fibrosis","volume":"23","author":"Patil","year":"2022","journal-title":"J Med"},{"key":"R25-20251015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/japt.japt_27_22","article-title":"Role of C-reactive protein in COVID-19 pneumonia as \u201ca jack of all trades is a master of none!A single-center experience of 2000 cases","volume":"5","author":"Patil","year":"2022","journal-title":"J Assoc Pulmonologist Tamil Nadu"},{"key":"R26-20251015","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4103\/jmisr.jmisr_62_22","article-title":"Role of CRP in COVID-19 pneumonia: A single-center experience of 1000 cases in a tertiary care setting in India","volume":"5","author":"Patil","year":"2022","journal-title":"J Med Sci Res"},{"key":"R27-20251015","doi-asserted-by":"crossref","first-page":"95","DOI":"10.23736\/S2532-1285.22.00143-4","article-title":"Correlation of LDH with duration of illness, disease severity, ventilatory support and lung fibrosis in COVID-19 pneumonia: A single center experience of 1000 cases in tertiary care setting in India","volume":"11","author":"Patil","year":"2022","journal-title":"Ital J Emerg Med"},{"key":"R28-20251015","first-page":"7","article-title":"Role of lactate dehydrogenase in COVID19 pneumonia: A single tertiary care center follow-up experience of 1000 cases in India","volume":"1","author":"Patil","year":"2023","journal-title":"J One Health Res"},{"key":"R29-20251015","first-page":"10","article-title":"Role of initial and follow-up LDH titer in COVID-19 pneumonia: A single center experience of 2000 cases in tertiary care setting in India","volume":"24","author":"Patil","year":"2023","journal-title":"J Med"},{"key":"R30-20251015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/cjhr.cjhr_82_22","article-title":"Role of initial and follow-up lactate dehydrogenase titer in coronavirus disease 2019 pneumonia: A single-center experience","volume":"10","author":"Patil","year":"2023","journal-title":"CHRISMED J Health Res"},{"key":"R31-20251015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/ijrc.ijrc_47_22","article-title":"Role of ferritin as \u201ccore marker\u201d in the assessment of severity, response to therapy and predicting outcome in COVID-19 pneumonia: A large, two-center, prospective, observational study of 1000 cases in tertiary care setting in India","volume":"11","author":"Patil","year":"2022","journal-title":"Indian J Respir Care"},{"key":"R32-20251015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4103\/mjmsr.mjmsr_19_22","article-title":"Role of \u201cferritin\u201d in COVID-19 pneumonia: Sensitive marker of inflammation, predictor of mechanical ventilation, and early marker of post COVID-lung fibrosis \u2013 A prospective, observational, and interventional study in a tertiary care setting in India","volume":"13","author":"Patil","year":"2022","journal-title":"Muller J Med Sci Res"},{"key":"R33-20251015","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s43162-022-00163-3","article-title":"Serial ferritin titer monitoring in COVID-19 pneumonia: Valuable inflammatory marker in assessment of severity and predicting early lung fibrosis \u2013Prospective, multicentric, observational, and interventional study in tertiary care setting in India","volume":"34","author":"Patil","year":"2022","journal-title":"Egypt J Intern Med"},{"key":"R34-20251015","first-page":"86","article-title":"Correlation of ferritin with the duration of illness, disease severity, oxygenation status, ventilatory requirement, and lung fibrosis in COVID-19 pneumonia: A single-center experience of 1000 cases in tertiary care setting in India","volume":"4","author":"Patil","year":"2022","journal-title":"Adesh Univ J Med Sci Res"},{"key":"R35-20251015","first-page":"31","article-title":"Role of D-dimer in assessing severity, monitoring, and predicating outcome in COVID-19 pneumonia: A single center study","volume":"1","author":"Patil","year":"2023","journal-title":"Glob J Health Sci Res"},{"key":"R36-20251015","first-page":"73","article-title":"Role of 'serial D-dimer level'in predicting severity and outcome in COVID-19 pneumonia: A prospective multicentric observational study of 1000 cases in tertiary care setting in India","volume":"2","author":"Patil","year":"2022","journal-title":"EJMA"},{"key":"R37-20251015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/aam.aam_47_22","article-title":"Does follow-up D-dimer level help in predicting oxygenation status, ventilatory support requirement, lung fibrosis, and thromboembolic events in coronavirus disease 2019 pneumonia? A prospective observational study in a tertiary care setting in India","volume":"22","author":"Patil","year":"2023","journal-title":"Ann Afr Med"},{"key":"R38-20251015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/jascp.jascp_46_22","article-title":"D-dimer in coronavirus disease 2019 pneumonia: A valuable inflammatory marker in predicting trends of systemic effects in addition to thromboembolic events!A single-center experience","volume":"4","author":"Patil","year":"2023","journal-title":"J Appl Sci Clin Pract"},{"key":"R39-20251015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/RID.RID_47_22","article-title":"Easy-to-treat and difficult-to-treat radiological phenotypes in coronavirus disease 2019 pneumonia: A single-center experience","volume":"10","author":"Patil","year":"2023","journal-title":"Radiol Infect Dis"},{"key":"R40-20251015","first-page":"71","article-title":"Radiological patterns integration with duration of illness in COVID-19 pneumonia as 'evolved'and 'evolving'radiological phenotypes: A single center experience","volume":"24","author":"Patil","year":"2023","journal-title":"J Med"},{"key":"R41-20251015","first-page":"46","article-title":"CT severity radiological phenotypes (CTS) assessment in COVID-19 pneumonia as 'inconsistent predictor of disease severity': A large tertiary care center study in India","volume":"25","author":"Patil","year":"2024","journal-title":"J Med"},{"key":"R42-20251015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/rid.RID-D-23-00008","article-title":"Residual lung abnormalities in recovered COVID-19 cases at 1-year follow-up: A single-center final radiological outcome phenotype study in India","volume":"10","author":"Patil","year":"2023","journal-title":"Radiol Infect Dis"},{"key":"R43-20251015","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2337\/dbi21-0029","article-title":"COVID-19-induced new-onset diabetes: Trends and technologies","volume":"70","author":"Metwally","year":"2021","journal-title":"Diabetes"},{"key":"R44-20251015","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/dom.14099","article-title":"Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"R45-20251015","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2213-8587(20)30221-7","article-title":"Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: A retrospective case series","volume":"8","author":"Armeni","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R46-20251015","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pcd.2020.08.014","article-title":"Newly diagnosed diabetes in COVID-19 patients","volume":"15","author":"Sathish","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"R47-20251015","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1007\/s00125-020-05209-1","article-title":"Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: A multi-centre retrospective study","volume":"63","author":"Wang","year":"2020","journal-title":"Diabetologia"},{"key":"R48-20251015","doi-asserted-by":"crossref","first-page":"108374","DOI":"10.1016\/j.diabres.2020.108374","article-title":"Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration","volume":"168","author":"Fadini","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"R49-20251015","doi-asserted-by":"crossref","first-page":"e003052","DOI":"10.1136\/bmjdrc-2022-003052","article-title":"Time-varying association of acute and post-acute COVID-19 with new-onset diabetes mellitus among hospitalized and non-hospitalized patients","volume":"11","author":"Reges","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R50-20251015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.pcd.2022.05.009","article-title":"Risk of incident diabetes post-COVID-19: A systematic review and meta-analysis","volume":"16","author":"Banerjee","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"R51-20251015","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: A cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R52-20251015","first-page":"e172","article-title":"Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany?Diabetes Care","volume":"43","author":"Tittel","year":"2020"},{"key":"R53-20251015","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1210\/clinem\/dgab792","article-title":"No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"107","author":"Laurenzi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R54-20251015","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/dom.14659","article-title":"Risk of new-onset type 2 diabetes mellitus in 600,055 persons after COVID-19: A cohort study","volume":"24","author":"Birabaharan","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"R55-20251015","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.4103\/jfmpc.jfmpc_316_22","article-title":"New onset diabetes mellitus in post-COVID-19 patients","volume":"11","author":"Keerthi","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"R56-20251015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12020-023-03611-4","article-title":"Association between newly diagnosed hyperglycemia\/diabetes mellitus, atherogenic index of plasma and obesity in post-COVID-19 syndrome patients","volume":"84","author":"Emiroglu","year":"2024","journal-title":"Endocrine"},{"key":"R57-20251015","first-page":"9652940","article-title":"New onset of diabetes mellitus and associated factors among COVID-19 patients in COVID-19 care centers, Addis Ababa, Ethiopia 2022","author":"Sane","year":"2022","journal-title":"J Diabetes Res 2022"},{"key":"R58-20251015","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.3390\/jcm11113094","article-title":"The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan","volume":"11","author":"Zhang","year":"2022","journal-title":"J Clin Med"},{"key":"R59-20251015","doi-asserted-by":"crossref","first-page":"n1098","DOI":"10.1136\/bmj.n1098","article-title":"Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study","volume":"373","author":"Daugherty","year":"2021","journal-title":"BMJ"},{"key":"R60-20251015","first-page":"53","article-title":"Effect of COVID 19 on pre-existent hypertension and its impact on unmasking new onset hypertension in recovered cases: A single center experience","volume":"8","author":"Kulkarni","year":"2024","journal-title":"J Med Sci Res"},{"key":"R61-20251015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"R62-20251015","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/03007995.2022.2042991","article-title":"Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: A cross-sectional study","volume":"38","author":"Maamar","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"R63-20251015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5501\/wjv.v10.i5.275","article-title":"New-onset diabetes in COVID-19 and clinical outcomes: A systematic review and meta-analysis","volume":"10","author":"Shrestha","year":"2021","journal-title":"World J Virol"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_20_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:26:50Z","timestamp":1787837210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_20_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_20_25","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"2025-01-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}